Omentin-1, also known as intelectin-1 (ITLN1), is a novel adipokine with 313 amino acids; it can be used as a marker of obesity and metabolic disorders, including insulin resistance, diabetes, and metabolic syndrome [18–20]. Here, ITLN1 is linked to metabolic disease.